PROtein Analytics for Kinase Therapeutic Inhibitor Variants (PROAKTIV): A Machine learning approach to predict efficacy of tyrosine kinase inhibitors against mutations in EGFR, ALK and BRAF

Research Square 2026 Preprint Open access

Read full text

Authors: Harold Mateo Mojica Urrego, Matthew R. Groves, Anthonie J. van der Wekken, Juvenal Yosa Reyes

DOI: 10.21203/rs.3.rs-8730878/v1

Cited by: 0

References: 44

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Computational Drug Discovery Methods Machine Learning in Bioinformatics

References 44